Existing research cooperation develops into strong application and market driven collaboration. Potential applications include solar cells, holograms, organic light- emitting devices for signage, sensors and photo diodes.
Applied Materials, Inc. today announced that it has made a non-binding proposal to ASM International N.V. for the possible acquisition by Applied Materials of the Atomic Layer Deposition and Chemical Vapor Deposition businesses of ASMI for a price up to a range of U.S. $400 million to U.S. $500 million, subject to due diligence.
Nanogen, Inc., developer of in vitro diagnostic products, announced today it has been awarded a new $10.4 million, two-year contract from the U.S. Centers for Disease Control and Prevention (CDC) to develop a multi-analyte molecular diagnostic assay for Influenza.
The NanoBusiness Alliance today announced keynote sessions scheduled for the premiere of their newest conference, the Nano Renewable Energy Summit, being held July 20 - 22 at The Cable Center at the University of Colorado.
Catalyx Nanotech, Inc., announced that it has begun manufacturing Platelet Graphite Nanofibers (PGNF) at a fraction of competitors? costs on a small commercial scale, with current production capacity at 250-500 Kg per year.
Akrion, Inc., a supplier of advanced surface preparation equipment, and CEA-Liten (Laboratory of Innovation for New Energy Technologies and Nanomaterials), a French public technological research organization, have signed an agreement to collaborate on the development of silicon-based heterojunction solar cells until at least the end of 2009.
The European Commission today has given its green light for the funding of the Genesis program, which is opening the way for the development in Europe of an innovative and competitive sector in nanostructured materials.
Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced today that its chief executive officer, Laurent Levy, has been elected as co-president of the French Technology Platform on Nanomedicine, effective immediately.
Quest Diagnostics Incorporated today announced results of a study that demonstrates that a novel diagnostic testing technique it has developed is the first to provide direct, accurate and reproducible physical measurement of both the size and concentration of a broad range of lipoproteins in blood plasma.